Add Yahoo as a preferred source to see more of our stories on Google. Hims & Hers’ Super Bowl ad plugs its compounded weight loss drugs as the “affordable” solution to a “sick system,” but many ...

While U.S. shortages of Novo and Lilly's immensely popular GLP-1 drugs have been formally resolved by the FDA, access barriers to the lucrative weight loss and diabetes medications remain. Still, ...

The US Food and Drug Administration (FDA) late Friday issued revised versions of two final guidance documents explaining the use of bulk drug substances in compounding and clarifying that the agency ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients. Copycat medications, produced through a ...